Opus Genetics

Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company developing important new therapies for the treatment of IRDs and other retinal and refractive disorders.

  • Headcount
  • Financials
  • Funding
  • Mergers & Acquisitions
  • Products and services
  • Similar companies

Get it all with one API call

from tavily import TavilyClientclient = TavilyClient(api_key="tvly-YOUR_API_KEY")response = client.extract(urls=["https://tavily.com/knowledge/company/3Hn8ci6QjcQd"])print(response)
Get an API keyRead the docs

Tavily’s entity index compiles information from sources on the web. Information may be inaccurate, incomplete, or outdated, and entity resolution may incorrectly associate information with a person or company. Users should independently verify information before relying on it. To report inaccurate information or exercise your privacy rights, please visit our Privacy Requests page.